Kiromic BioPharma Welcomes Two New Directors to its Board
| KRBPDelisted Stock | USD 2.68 0.07 2.55% |
Slightly above 62% of Kiromic Biopharma's investor base is looking to short. The analysis of overall sentiment of trading Kiromic Biopharma stock suggests that many investors are alarmed at this time. Kiromic Biopharma's investing sentiment overview a quick insight into current market opportunities from investing in Kiromic Biopharma. Many technical investors use Kiromic Biopharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Kiromic |
Kiromic BioPharma, Inc. , a clinical-stage, fully-integrated biotherapeutics company using its proprietary
Read at businesswire.com
 |
Kiromic Biopharma Fundamental Analysis
We analyze Kiromic Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kiromic Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kiromic Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Kiromic Biopharma is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Kiromic Biopharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kiromic Biopharma stock to make a market-neutral strategy. Peer analysis of Kiromic Biopharma could also be used in its relative valuation, which is a method of valuing Kiromic Biopharma by comparing valuation metrics with similar companies.
Peers
Kiromic Biopharma Related Equities
| QNRX | Quoin Pharmaceuticals | 13.79 | ||||
| ZURA | Zura Bio | 6.82 | ||||
| UNCY | Unicycive Therapeutics | 5.17 | ||||
| BDRX | Biodexa Pharmaceticals | 4.01 | ||||
| RVPH | Reviva Pharmaceuticals | 2.72 | ||||
| ZVSA | ZyVersa Therapeutics | 0.72 | ||||
| IMMX | Immix Biopharma | 1.52 | ||||
| SONN | Sonnet Biotherapeutics | 4.62 | ||||
| PALI | Palisade Bio | 4.90 | ||||
| ALLR | Allarity Therapeutics | 5.08 | ||||
| VRAX | Virax Biolabs | 11.98 | ||||
| ENVB | Enveric Biosciences | 46.41 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Kiromic Stock
If you are still planning to invest in Kiromic Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kiromic Biopharma's history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |